OrganiGram Holdings Other Stockholder Equity Over Time
| OGI Stock | USD 1.50 0.03 2.04% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out OrganiGram Holdings Performance and OrganiGram Holdings Correlation. OrganiGram |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.79) | Revenue Per Share 1.835 | Quarterly Revenue Growth (0.14) | Return On Assets (0.06) | Return On Equity (0.55) |
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Stockholder Equity Analysis
Compare OrganiGram Holdings and related stocks such as Bausch Health Companies, Haleon plc, and Intracellular Th Other Stockholder Equity Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BHC | 13.7 M | 276.1 M | 267.1 M | 228.9 M | 243.9 M | 304.9 M | 351 M | 380 M | 413 M | 429 M | 454 M | 462 M | 159 M | 214 M | 203.3 M |
| HLN | 20.8 B | 20.8 B | 20.8 B | 20.8 B | 20.8 B | 20.8 B | 20.8 B | 20.8 B | 20.8 B | 20.8 B | (11.7 B) | (448 M) | (11.7 B) | (11 B) | (10.4 B) |
| ITCI | 50.9 M | 50.9 M | 50.9 M | 89.2 M | 208.9 M | 669.9 M | 685.3 M | 862.5 M | 880.8 M | 905 M | 1.6 B | 1.6 B | 2.1 B | 2.2 B | 2.3 B |
OrganiGram Holdings and related stocks such as Bausch Health Companies, Haleon plc, and Intracellular Th Other Stockholder Equity description
My Equities
My Current Equities and Potential Positions
| OrganiGram Holdings | OGI |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | New Brunswick; Canada |
| Exchange | NASDAQ Exchange |
USD 1.5
Check out OrganiGram Holdings Performance and OrganiGram Holdings Correlation. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
OrganiGram Holdings technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.